Development of Dual PLD1/2 and PLD2 Selective Inhibitors from a Common 1,3,8-Triazaspiro[4.5]decane Core: Discovery of ML298 and ML299 That Decrease Invasive Migration in U87-MG Glioblastoma Cells

被引：54

作者：

O'Reilly, Matthew C. ^{[3
]}

Scott, Sarah A. ^{[1
,4
]}

Brown, Kyle A. ^{[1
,2
,3
]}

Oguin, Thomas H., III ^{[5
]}

Thomas, Paul G. ^{[5
]}

Daniels, J. Scott ^{[1
,2
,4
]}

Morrison, Ryan ^{[1
,2
,4
]}

Brown, H. Alex ^{[1
,3
]}

Lindsley, Craig W. ^{[1
,2
,3
,4
]}

机构：

[1] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA

[2] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA

[3] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA

[4] Vanderbilt Univ, Vanderbilt Specialized Chem Accelerated Probe Dev, Nashville, TN 37232 USA

[5] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2013年 / 56卷 / 06期

关键词：

PHOSPHOLIPASE D2; DESIGN; HALOPEMIDE;

D O I：

10.1021/jm301782e

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

An iterative parallel synthesis effort identified a PLD2 selective inhibitor, ML298 (PLD1 IC50 > 20 000 nM, PLD2 IC50 = 355 nM) and a dual PLD1/2 inhibitor, ML299 (PLD1 IC50 = 6 nM, PLD2 IC50 = 20 nM). SAR studies revealed that a small structural change (incorporation of a methyl group) increased PLD1 activity within this classically PLD2-preferring core and that the effect was enantiospecific. Both probes decreased invasive migration in U87-MG glioblastoma cells.

引用

页码：2695 / 2699

页数：5

共 16 条

[1] Biochemical analysis of phospholipase D [J].

Brown, H. Alex ;

Henage, Lee G. ;

Preininger, Anita M. ;

Xiang, Yun ;

Exton, John H. .

LIPIDOMICS AND BIOACTIVE LIPIDS: LIPIDS AND CELL SIGNALING, 2007, 434 :49-87

[2] Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders [J].

Conn, P. Jeffrey ;

Christopoulos, Arthur ;

Lindsley, Craig W. .

NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) :41-54

[3] THE CLINICAL-SIGNIFICANCE OF HALOPEMIDE, A DOPAMINE-BLOCKER RELATED TO THE BUTYROPHENONES [J].

DECUYPER, H ;

VANPRAAG, HM ;

VERSTRAETEN, D .

NEUROPSYCHOBIOLOGY, 1984, 12 (04) :211-216

[4] Impaired αIIbβ3 Integrin Activation and Shear-Dependent Thrombus Formation in Mice Lacking Phospholipase D1 [J].

Elvers, Margitta ;

Stegner, David ;

Hagedorn, Ina ;

Kleinschnitz, Christoph ;

Braun, Attila ;

Kuijpers, Marijke E. J. ;

Boesl, Michael ;

Chen, Qin ;

Heemskerk, Johan W. M. ;

Stoll, Guido ;

Frohman, Michael A. ;

Nieswandt, Bernhard .

SCIENCE SIGNALING, 2010, 3 (103) :ra1

[5] Phosphatidic acid signaling to mTOR: Signals for the survival of human cancer cells [J].

Foster, David A. .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2009, 1791 (09) :949-955

[6] Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity [J].

Lavieri, Robert ;

Scott, Sarah A. ;

Lewis, Jana A. ;

Selvy, Paige E. ;

Armstrong, Michelle D. ;

Brown, H. Alex ;

Lindsley, Craig W. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (08) :2240-2243

[7] Design, Synthesis, and Biological Evaluation of Halogenated N-(2-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: Discovery of an Isoform-Selective Small Molecule Phospholipase D2 Inhibitor [J].

Lavieri, Robert R. ;

Scott, Sarah A. ;

Selvy, Paige E. ;

Kim, Kwangho ;

Jadhav, Satyawan ;

Morrison, Ryan I. ;

Daniels, J. Scott ;

Brown, H. Alex ;

Lindsley, Craig W. .

JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (18) :6706-6719

[8] Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity [J].

Lewis, Jana A. ;

Scott, Sarah A. ;

Lavieri, Robert ;

Buck, Jason R. ;

Selvy, Paige E. ;

Stoops, Sydney L. ;

Armstrong, Michelle D. ;

Brown, H. Alex ;

Lindsley, Craig W. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (07) :1916-1920

[9] Optimization of halopemide for phospholipase D2 inhibition [J].

Monovich, Lauren ;

Mugrage, Benjamin ;

Quadros, Elizabeth ;

Toscano, Karen ;

Tommasi, Ruben ;

LaVoie, Stacey ;

Liu, Eugene ;

Du, Zhengming ;

LaSala, Daniel ;

Boyar, William ;

Steed, Paul .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (08) :2310-2311

[10] Overexpression of phospholipase D1 in human breast cancer tissues [J].

Noh, DY ;

Ahn, SJ ;

Lee, RA ;

Park, IA ;

Kim, JH ;

Suh, PG ;

Ryu, SH ;

Lee, KH ;

Han, JS .

CANCER LETTERS, 2000, 161 (02) :207-214

← 1 2 →